Akèy › Kasinom Selil Transizyonèl (Urotelyal) › Idaho › Boise
Etid klinik pou Kasinom Selil Transizyonèl (Urotelyal) nan Boise, ID
3 etid pou Kasinom Selil Transizyonèl (Urotelyal) ap chèche patisipan nan sit nan ak bò kote Boise (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
Ap rekriteFaz 2
- Saint Alphonsus Cancer Care Center-Boise, Boise
A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
Ap rekriteFaz 3
- St. Luke's Cancer Institute: Boise, Boise
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Ap rekriteEtid obsèvasyon
- Massive Bio SYNERGY-AI site, Boise
Etid Kasinom Selil Transizyonèl (Urotelyal) nan lòt vil
- Nashville, TN23 etid
- New York City, NY22 etid
- Houston, TX19 etid
- Dallas, TX18 etid
- Edison, NJ18 etid
- Los Angeles, CA17 etid
- Queens, NY15 etid
- Chicago, IL14 etid
- Arlington, VA12 etid
- Boston, MA11 etid
- San Antonio, TX11 etid
- Austin, TX10 etid
Lòt etid nan Boise
- Kansè Poumon ki pa ti selil14 etid
- Kansè poumon11 etid
- Leksemi mieloïd egi8 etid
- Kansè pwostat8 etid
- Kansè kolon7 etid
- Kansè kolorektal6 etid
- Sindrom detres respiratwa6 etid
- Kansè nan tete6 etid
- Melanom6 etid
- Limfòm Burkitt5 etid
- Kansè pankreyas4 etid
- Neoplazmi myeloproliferatif4 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.